[1] Irshad M,Mankotia DS,Irshad K.An insight into the diagnosis and pathogenesis of hepatitis C virus infection.World J Gastroenterol,2013,19:7896-7909.
[2] Younossi ZM,Stepanova M,Nader F,et al.Associations of chronic hepatitis C with metabolic and cardiac outcomes.Aliment Pharmacol Ther,2013,37:647-652.
[3] Adela R,Banerjee SK.GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases:A Translational Prospective.J Diabetes Res,2015,2015:1-14.
[4] Richardson P,McKenna W,Bristow M,et al.Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.Circulation,1996,93:841-842.
[5] Okabe M,Fukuda K,Arakawa K,et al.Chronic variant of myocarditis associated with hepatitis C virus infection.Circulation,1997,96: 22-24.
[6] Baughman KL. Diagnosis of myocarditis: death of Dallas criteria.Circulation,2006,113:593-595.
[7] Zhu ZD,Sun T.Association between growth differentiation factor-15 and chronic heart failurein in coronary atherosclerosis patients.Genet Mol Res,2015,14:2225-2233.
[8] Butt AA,Xiaoqiang W,Budoff M,et al.Hepatitis C virus infection and the risk of coronary disease.Clin Infect Dis,2009,49:225-232. |
